Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1991 Dec;75(12):737–739. doi: 10.1136/bjo.75.12.737

Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.

J A Mauriello 1, J Aljian 1
PMCID: PMC1042555  PMID: 1768664

Abstract

To determine the long-term efficacy of botulinum toxin injections for the treatment of facial dyskinesias we studied 50 consecutive patients with blepharospasm, hemifacial spasm, and Meige syndrome. All received their first injection between September 1983 and June 1984. A total of 520 injections were given; the average number of injections per patient was 10.4 over the seven-year period ending September 1990. Twenty-six (52%) of the patients continued to return for periodic injections, while three patients no longer receive injections since they failed to respond adequately to treatment. Three patients with blepharospasm were in remission and required no further treatment, after a series of six, four, and three injections. Six patients were treated until they died of causes unrelated to facial dyskinesia or its treatment. Six patients are still being treated elsewhere because they could obtain injections closer to their homes. Five of the original 50 patients have been lost to follow-up. A patient with hemifacial spasm had one injection with good result but was not sufficiently bothered by her disease to return for reinjection. Complications were transient, minimal, well tolerated, and did not increase with increased number of injections.

Full text

PDF
737

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen D. A., Savino P. J., Stern M. B., Hurtig H. I. Botulinum injection therapy for blepharospasm: a review and report of 75 patients. Clin Neuropharmacol. 1986;9(5):415–429. doi: 10.1097/00002826-198610000-00002. [DOI] [PubMed] [Google Scholar]
  2. Dutton J. J., Buckley E. G. Botulinum toxin in the management of blepharospasm. Arch Neurol. 1986 Apr;43(4):380–382. doi: 10.1001/archneur.1986.00520040060020. [DOI] [PubMed] [Google Scholar]
  3. Dutton J. J., Buckley E. G. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988 Nov;95(11):1529–1534. doi: 10.1016/s0161-6420(88)32977-5. [DOI] [PubMed] [Google Scholar]
  4. Elston J. S. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol. 1987 Sep;71(9):664–668. doi: 10.1136/bjo.71.9.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engstrom P. F., Arnoult J. B., Mazow M. L., Prager T. C., Wilkins R. B., Byrd W. A., Hofmann R. J. Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology. 1987 Aug;94(8):971–975. doi: 10.1016/s0161-6420(87)33338-x. [DOI] [PubMed] [Google Scholar]
  6. Fahn S. The varied clinical expressions of dystonia. Neurol Clin. 1984 Aug;2(3):541–554. [PubMed] [Google Scholar]
  7. Frueh B. R., Musch D. C. Treatment of facial spasm with botulinum toxin. An interim report. Ophthalmology. 1986 Jul;93(7):917–923. doi: 10.1016/s0161-6420(86)33641-8. [DOI] [PubMed] [Google Scholar]
  8. Grandas F., Elston J., Quinn N., Marsden C. D. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):767–772. doi: 10.1136/jnnp.51.6.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jankovic J. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. Adv Neurol. 1988;50:583–591. [PubMed] [Google Scholar]
  10. Jankovic J., Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983 Apr;13(4):402–411. doi: 10.1002/ana.410130406. [DOI] [PubMed] [Google Scholar]
  11. Jordan D. R., Patrinely J. R., Anderson R. L., Thiese S. M. Essential blepharospasm and related dystonias. Surv Ophthalmol. 1989 Sep-Oct;34(2):123–132. doi: 10.1016/0039-6257(89)90040-4. [DOI] [PubMed] [Google Scholar]
  12. Kraft S. P., Lang A. E. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci. 1988 Aug;15(3):276–280. doi: 10.1017/s0317167100027748. [DOI] [PubMed] [Google Scholar]
  13. Mauriello J. A., Jr Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985 Oct;35(10):1499–1500. doi: 10.1212/wnl.35.10.1499. [DOI] [PubMed] [Google Scholar]
  14. Mauriello J. A., Jr, Coniaris H., Haupt E. J. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias. Ophthalmology. 1987 Aug;94(8):976–979. doi: 10.1016/s0161-6420(87)33337-8. [DOI] [PubMed] [Google Scholar]
  15. Savino P. J., Sergott R. C., Bosley T. M., Schatz N. J. Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol. 1985 Sep;103(9):1305–1306. doi: 10.1001/archopht.1985.01050090057031. [DOI] [PubMed] [Google Scholar]
  16. Scott A. B., Kennedy R. A., Stubbs H. A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985 Mar;103(3):347–350. doi: 10.1001/archopht.1985.01050030043017. [DOI] [PubMed] [Google Scholar]
  17. Shore J. W., Leone C. R., Jr, O'Connor P. S., Neuhaus R. W., Arnold A. C. Botulinum toxin for the treatment of essential blepharospasm. Ophthalmic Surg. 1986 Nov;17(11):747–753. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES